Literature DB >> 1347036

Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients.

K Kawashima1, S Nomura, H Hirai, S Fukushi, T Karube, K Takeuchi, T Naruke, S Nishimura.   

Abstract

For further study of the correlation of L-myc restriction-fragment-length polymorphism (RFLP) and metastasis of lung cancer to lymph nodes or other organs at the time of surgery, L-myc RFLP was analyzed in 252 Japanese lung-cancer patients. A close correlation between L-myc RFLP and metastasis was confirmed in this large number of patients (p = 0.01). The correlation was particularly pronounced in cases of adenocarcinoma and squamous-cell carcinoma. Poor prognosis (additional metastases after surgery) was observed in lung-cancer patients with L-S (identified as long and short bands produced with EcoRI) and S-S type L-myc RFLP. In addition, the death rate of lung-cancer patients with the L-S and S-S types was greater than that of those with the L-L type. Lung-cancer patients of the L-S and S-S types had almost 4 times higher incidence of multiple cancer in the lung, pharynx and other organs than those with the L-L type. Our results indicate that, in patients with lung cancer, genetic disposition with respect to the L-myc gene influences the extent of metastasis, the incidence of multiple cancers and prognosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347036     DOI: 10.1002/ijc.2910500411

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.

Authors:  I Zborovskaya; A Gasparian; M Kitaeva; B Polotzky; N Tupitzin; Z Machaladze; S Gerasimov; M Shtutman; M Jakubovskaya; M Davidov; A Tatosyan
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

2.  Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases.

Authors:  M Volm; G van Kaick; J Mattern
Journal:  Clin Exp Metastasis       Date:  1994-07       Impact factor: 5.150

3.  A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.

Authors:  Francesca Colombo; Felicia S Falvella; Antonella Galvan; Elisa Frullanti; Hideo Kunitoh; Toshikazu Ushijima; Tommaso A Dragani
Journal:  Mol Cancer       Date:  2011-07-07       Impact factor: 27.401

4.  MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.

Authors:  K M Fong; Y Kida; P V Zimmerman; P J Smith
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

5.  L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.

Authors:  K Shibuta; H Inoue; K Sato; A Matsuyama; H Ueo; Y Tanaka; K Mafune; G F Barnard; M Mori
Journal:  Jpn J Cancer Res       Date:  2000-02

6.  Different susceptibility of each L-myc genotype to esophageal cancer risk factors.

Authors:  H Kumimoto; N Hamajima; K Nishizawa; Y Nishimoto; K Matsuo; H Harada; M Shinoda; S Hatooka; K Ishizaki
Journal:  Jpn J Cancer Res       Date:  2001-07

7.  L-myc genotype is associated with different susceptibility to lung cancer in smokers.

Authors:  Hiroshi Kumimoto; Nobuyuki Hamajima; Yoshio Nishimoto; Keitaro Matsuo; Masayuki Shinoda; Shunzo Hatooka; Kanji Ishizaki
Journal:  Jpn J Cancer Res       Date:  2002-01

8.  Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.

Authors:  P E Crossen; M J Morrison; B M Colls
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.